Business
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Jesper Høiland as Head of Strategy. Mr. Høiland has served as a strategic adviser to the company since 2023 and brings more than 30 years of global pharmaceutical leadership experience, including extensive expertise in obesity and metabo
About this update from Strategy Inc
[{"type":"image","alt":"Rani Therapeutics, LLC","displaySize":"","headline":null,"caption":"Rani Therapeutics, LLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/eedd36d474bbaf8ede890d5712b0f73a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JUKcnllz1CeH_EQCjw_5jQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMA--/https://media.zenfs.com/en/globenewswire.com/eedd36d474bbaf8ede890d5712b0f73a","width":300,"height":150}},"lazy":false},{"type":"text","content":"SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Jesper Høiland as Head of Strategy. Mr. Høiland has served as a strategic adviser to the company since 2023 and brings more than 30 years of global pharmaceutical leadership experience, including extensive expertise in obesity and metabolic disease.","length":512,"tagName":"p"},{"type":"text","content":"“Jesper is a highly respected leader with a rare combination of strategic insight and deep commercial experience, and we are thrilled to welcome him as Head of Strategy,” said Talat Imran, Chief Executive Officer of Rani. “As we continue to expand our pipeline and evaluate new opportunities for the RaniPill® platform, Jesper will play a critical role in helping us prioritize the most impactful programs and align our strategy with areas of greatest clinical and market potential. His experience across global organizations and therapeutic areas, along with his strong industry relationships, will be invaluable as we advance our partnering strategy and continue to build a differentiated pipeline.”","length":701,"tagName":"p"},{"type":"text","content":"In this newly created adviser role, Mr. Høiland will be responsible for shaping Rani’s corporate and pipeline strategy, including prioritization of internal programs, evaluation of new therapeutic opportunities, and support of the company’s partnering and business development efforts. He will work closely with the executive team to align development decisions with long-term strategic and market considerations.","length":413,"tagName":"p"},{"type":"text","content":"Mr. Høiland brings more than three decades of ex...